| Xiaoru Yang, MD | |
|
1901 Tate Springs Rd, Lynchburg, VA 24501-1109 | |
| (434) 200-5895 | |
| (434) 200-7529 |
| Full Name | Xiaoru Yang |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 22 Years |
| Location | 1901 Tate Springs Rd, Lynchburg, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851636658 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 0101260009 (Virginia) | Secondary |
| 208M00000X | Hospitalist | 0101260009 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centra Health - Lynchburg Gen Hospital | Lynchburg, VA | Hospital |
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Centra Southside Community Hospital, Inc | Farmville, VA | Hospital |
| Spotsylvania Regional Medical Center | Fredericksburg, VA | Hospital |
| Centra Bedford Memorial Hospital | Bedford, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centra Medical Group Llc | 4789606088 | 603 |
| Nephrology Medical Associates Of Georgia, Llc | 5991600629 | 15 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced publication of data from a phase I study demonstrating that the antisense oligonucleotide GS-101 (eye drops) is safe, with no signs of intolerability following administration to healthy volunteers.
Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS".
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program - called MAINTAIN, or Medicines Assistance for Those who Are in Need - will begin July 1.
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Peripheral nerves — the nerves outside the brain and spinal cord — have the capacity for regeneration, but the rate of renewal is so slow that many nerve injuries lead to incomplete recovery and permanent disability for patients.
› Verified 4 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced publication of data from a phase I study demonstrating that the antisense oligonucleotide GS-101 (eye drops) is safe, with no signs of intolerability following administration to healthy volunteers.
Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS".
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program - called MAINTAIN, or Medicines Assistance for Those who Are in Need - will begin July 1.
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Peripheral nerves — the nerves outside the brain and spinal cord — have the capacity for regeneration, but the rate of renewal is so slow that many nerve injuries lead to incomplete recovery and permanent disability for patients.
› Verified 4 days ago
| Entity Name | Nephrology Medical Associates Of Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114344926 PECOS PAC ID: 5991600629 Enrollment ID: O20140806000674 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced publication of data from a phase I study demonstrating that the antisense oligonucleotide GS-101 (eye drops) is safe, with no signs of intolerability following administration to healthy volunteers.
Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS".
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program - called MAINTAIN, or Medicines Assistance for Those who Are in Need - will begin July 1.
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Peripheral nerves — the nerves outside the brain and spinal cord — have the capacity for regeneration, but the rate of renewal is so slow that many nerve injuries lead to incomplete recovery and permanent disability for patients.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Xiaoru Yang, MD 1901 Tate Springs Rd, Lynchburg, VA 24501-1109 Ph: (434) 200-5895 | Xiaoru Yang, MD 1901 Tate Springs Rd, Lynchburg, VA 24501-1109 Ph: (434) 200-5895 |
News Archive
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced publication of data from a phase I study demonstrating that the antisense oligonucleotide GS-101 (eye drops) is safe, with no signs of intolerability following administration to healthy volunteers.
Addus HomeCare Corporation announced today that it has priced the initial public offering of 5,400,000 shares of its common stock at $10.00 per share. Addus shares will begin trading on October 28, 2009 on the Nasdaq Global Market under the ticker symbol "ADUS".
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program - called MAINTAIN, or Medicines Assistance for Those who Are in Need - will begin July 1.
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Peripheral nerves — the nerves outside the brain and spinal cord — have the capacity for regeneration, but the rate of renewal is so slow that many nerve injuries lead to incomplete recovery and permanent disability for patients.
› Verified 4 days ago
Aric Jordan Moran, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-5252 | |
James Pittard, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-5895 Fax: 434-200-7529 | |
Dr. Robert Matthew Feuerstein, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-5895 | |
Samuel P Sawyer, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-5895 Fax: 434-200-7529 | |
Kensley Nichols, M.D. Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 2215 Landover Pl, Lynchburg, VA 24501 Phone: 434-947-3944 Fax: 434-544-2337 | |
Gabrielle K. Jackson, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-5895 Fax: 434-200-7529 | |
Dr. Richard S Kuk, MD Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 2410 Atherholt Rd, Lynchburg, VA 24501 Phone: 434-200-5252 Fax: 434-200-2862 |